These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 7694265)
1. Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma. Huang CL; Brassil D; Rozzell M; Schellhammer PF; Wright GL Prostate; 1993; 23(3):201-12. PubMed ID: 7694265 [TBL] [Abstract][Full Text] [Related]
2. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate. Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia. Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815 [TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609 [TBL] [Abstract][Full Text] [Related]
5. Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia. Shih WJ; Collins J; Mitchell B; Wierzbinski B J Natl Med Assoc; 1994 Sep; 86(9):667-70. PubMed ID: 7525979 [TBL] [Abstract][Full Text] [Related]
7. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma]. Bentvelsen FM; Bogdanowicz JF; Oosterom R; Schröder FH Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1596-600. PubMed ID: 1697651 [TBL] [Abstract][Full Text] [Related]
8. What is the 'normal range' for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker. Gillatt D; Reynard JM Br J Urol; 1995 Mar; 75(3):341-6. PubMed ID: 7537603 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease. Buamah PK; Johnson P; Skillen AW Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396 [TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer. Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860 [TBL] [Abstract][Full Text] [Related]
11. Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer? Omacini S; Mione R; Barichello M; Santucci Delli Ponti U; Bolgan A; Contemori GP; Petracco S; Capitanio G; Donisi PM; Gion M Eur Urol; 1992; 21 Suppl 1():108-10. PubMed ID: 1385128 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. Seamonds B; Yang N; Anderson K; Whitaker B; Shaw LM; Bollinger JR Urology; 1986 Dec; 28(6):472-9. PubMed ID: 2431533 [TBL] [Abstract][Full Text] [Related]
13. Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase. Ferro MA; Barnes I; Roberts JB; Smith PJ Br J Urol; 1987 Jul; 60(1):69-73. PubMed ID: 2441790 [TBL] [Abstract][Full Text] [Related]
14. [Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue]. Fujino A; Mukai N; Kawakami T; Yokoyama E; Mashimo S; Endo T; Ishibashi A; Koshiba K; Aoki Y; Itoh H Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):541-50. PubMed ID: 1711133 [TBL] [Abstract][Full Text] [Related]
15. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay]. Akino H; Tsuka H; Okada K; Tsuchiya Y; Matsubara M; Arimura K Hinyokika Kiyo; 1995 Jun; 41(6):439-45. PubMed ID: 7544063 [TBL] [Abstract][Full Text] [Related]
16. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation. Dejter SW; Martin JS; McPherson RA; Lynch JH Urology; 1988 Oct; 32(4):288-92. PubMed ID: 2459831 [TBL] [Abstract][Full Text] [Related]
17. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate]. Morote Robles J; de Torres Mateos JA Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148 [TBL] [Abstract][Full Text] [Related]
18. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice. Csapo Z; Brand K; Walther R; Fokas K J Urol; 1988 Nov; 140(5):1032-8. PubMed ID: 2459419 [TBL] [Abstract][Full Text] [Related]
19. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience. Drago JR; Badalament RA; Wientjes MG; Smith JJ; Nesbitt JA; York JP; Ashton JJ; Neff JC Urology; 1989 Oct; 34(4):187-92. PubMed ID: 2477931 [TBL] [Abstract][Full Text] [Related]
20. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports]. Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J Ann Urol (Paris); 1989; 23(6):528-30. PubMed ID: 2482700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]